Zoetis Insider Sold Shares Worth $617,028, According to a Recent SEC Filing-February 2024-www.financetom.com

Zoetis Insider Sold Shares Worth $617,028, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Zoetis Insider Sold Shares Worth $617,028, According to a Recent SEC Filing

Nov 26, 2024 1:54 PM

04:32 PM EST, 11/26/2024 (MT Newswires) -- Robert J Polzer, Executive Vice President, on November 25, 2024, sold 3,477 shares in Zoetis ( ZTS ) for $617,028. Following the Form 4 filing with the SEC, Polzer has control over a total of 4,309 shares of the company, with 3,249 shares held directly and 1,060 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1555280/000155528024000339/xslF345X05/wk-form4_1732656461.xml

Previous page： Novartis loses initial bid to block generic of best-selling heart drug Next page： Update: Eli Lilly Looking to Issue Debt for Morphic Acquisition

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Novartis loses initial bid to block generic of best-selling heart drug

Aug 12, 2024

Aug 12 (Reuters) - Novartis failed to convince a Delaware federal court to block generic drugmaker MSN Pharmaceuticals from launching its own version of Novartis' blockbuster heart-failure drug Entresto, according to a court decision issued on Monday. U.S. District Judge Richard Andrews ruled that Novartis' chance of winning its patent-infringement lawsuit challenging the generic was too low to justify halting...

Update: Eli Lilly Looking to Issue Debt for Morphic Acquisition

Aug 12, 2024

03:45 PM EDT, 08/12/2024 (MT Newswires) -- (Updates to reflect Eli Lilly ( LLY ) declined comment to MT Newswires) Eli Lilly ( LLY ) filed a prospectus Monday to raise debt for its $3.2 billion acquisition of Morphic. According to a securities filing, the pharma company is looking to issue five separate series of notes to raise $5 billion...

Portillo's Insider Sold Shares Worth $679,675, According to a Recent SEC Filing

Aug 12, 2024

03:56 PM EDT, 08/12/2024 (MT Newswires) -- Michael Osanloo, Director, President & CEO, on August 09, 2024, sold 66,052 shares in Portillo's (PTLO) for $679,675. Following the Form 4 filing with the SEC, Osanloo has control over a total of 79,041 shares of the company, with 79,041 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1871509/000187150924000105/xslF345X03/wk-form4_1723492418.xml Price: 10.82, Change: +0.11, Percent Change: +1.03...

Esperion Therapeutics Shares Fall After Reporting Wider Than Expected Q2 Loss

Aug 12, 2024

03:45 PM EDT, 08/12/2024 (MT Newswires) -- Esperion Therapeutics ( ESPR ) shares were down nearly 8% in recent Monday trading after the company reported a wider-than-expected Q2 net loss. The company reported a Q2 net loss of $0.33 per diluted share, compared with a loss of $0.46 a year earlier. Analysts polled by Capital IQ expected a $0.18 loss....